Stanford’s 37,000‑Agent 'Virtual Biotech' Finds Trial‑Success Signal and Designs Lung‑Cancer Therapy
AI agents mined trial, genetic, molecular data to identify target features tied to higher trial success, with proposed therapies awaiting laboratory and clinical validation.